Pharmaceutical Logistics for Clinical Research in the UAE: What Sponsors & CROs Need to Plan

Short answer: Clinical trial logistics in the UAE means moving investigational medicinal products (IMPs) to trial sites under regulatory approval, Good Distribution Practice (GDP) and Good Clinical Practice (GCP). Sponsors and CROs need trial and import approvals in place, GDP-compliant storage separated from commercial stock, validated cold chain, trial-specific documentation and coordinated delivery to every site.

Clinical research in the UAE is growing, supported by national investment in healthcare innovation and a strong hospital network. But clinical trial supply chains are very different from commercial pharma logistics. Supplies are often small-volume, high-value and time-critical, and a single failed delivery can delay patient enrolment or compromise trial data.

This guide covers what sponsors and CROs should plan for, from regulatory approvals to site-level distribution.

Written by the Arib Health (Arib Shipping) pharmaceutical logistics team. Regulations change, so confirm current requirements with the relevant UAE authorities and your ethics committee before shipping.

How clinical trial logistics differs from commercial pharma logistics

Regulatory framework

• Health authority approval: Clinical trials and the import of investigational products need approval from the UAE health authorities. The Ministry of Health and Prevention (MOHAP) has been the key regulator for clinical trials, and the Emirates Drug Establishment (EDE) now oversees much of medicines regulation nationally. Confirm which body issues each approval for your trial.
• Ethics committee approval: Trials must be approved by the relevant research ethics committee or institutional review board (IRB), and site-level approvals may also apply, for example at DHA-licensed facilities in Dubai.
• Controlled substances: Narcotic, psychotropic and semi-controlled IMPs need additional permits. See our guide to controlled pharmaceutical shipping in the UAE.
• GDP and GCP: Logistics must follow Good Distribution Practice for storage and transport, and the trial itself must follow Good Clinical Practice, including product accountability and traceability.

Documentation for clinical trial shipments

Exact requirements depend on the product and trial, but sponsors and CROs should typically prepare:

• Import permit for IMPs from the relevant health authority
• Trial and ethics approvals covering the study and participating sites
• Certificate of Analysis (CoA) and, where relevant, GMP documentation
• Commercial or pro-forma invoice and packing list marked for clinical trial use only, with batch numbers and expiry dates
• Temperature records, such as data logger reports, for sensitive products
• Blinding and randomisation controls, usually managed through the sponsor’s trial systems. Logistics teams must handle blinded kits so that packaging, labels and paperwork never break the blind
• Chain-of-custody and accountability records from depot to site

Tip: Make sure labels, batch numbers and quantities match the import permit and the site’s shipment request exactly.

Storage and distribution in Dubai and the UAE

• GDP-compliant, authorised storage: Facilities should be qualified for pharmaceutical storage and approved for investigational products where required.
• Segregation: IMPs must be stored separately from commercial stock, with clear status control (quarantined, released, returned, expired).
• Cold chain validation: Vaccines, biologics and advanced therapies need validated packaging or vehicles and continuous temperature monitoring.
• Direct-to-site delivery: Deliver to hospitals, clinics and research centres in validated vehicles, with named receivers and signed proof of delivery.
• Returns and destruction: Plan for returns of unused IMPs, reconciliation and certified destruction under sponsor instructions.

Challenges for sponsors and CROs

• Regulatory complexity: Multiple approvals across authorities, ethics committees and sites can move at different speeds.
• Heat and cold chain risk: The UAE climate increases the risk of temperature excursions, especially during loading and handover.
• Documentation errors: Small mismatches can delay import clearance and site activation.
• Multi-site coordination: Deliveries must be synchronised with site readiness, patient visits and staff availability.
• Blinding and traceability: Mistakes in labelling or handling can compromise trial integrity.

Best practices for clinical trial logistics in the UAE

1. Engage regulators and ethics committees early. Build realistic approval timelines into your study plan.
2. Map every site and route. Confirm receiving hours, storage capacity and contact persons before the first shipment.
3. Validate packaging for local conditions. Test for Dubai summer temperatures and realistic transit times, not just standard lanes.
4. Use real-time monitoring. IoT sensors and GPS tracking give visibility and let teams act on excursions quickly.
5. Train everyone involved. CRO staff, couriers and site teams should understand GDP and GCP handling rules.
6. Define an excursion and deviation process. Agree in advance who is notified, how product is quarantined and how the sponsor decides on use.
7. Keep audit-ready records. Maintain complete chain-of-custody and temperature documentation for inspections and monitoring visits.

What to ask a clinical trial logistics provider

• Are your facilities and vehicles GDP-compliant and authorised in the UAE?
• Can you handle investigational and controlled products?
• Do you support blinded supplies and strict segregation?
• Can you provide real-time monitoring and full temperature reports?
• How do you manage urgent, patient-specific or last-minute site requests?
• What is your process for returns, reconciliation and destruction?

Frequently asked questions

What is clinical trial logistics?
It is the planning, storage, transport and tracking of investigational medicinal products, comparator drugs and trial materials from the sponsor or depot to trial sites, under regulatory and quality requirements.

Who regulates clinical trials and IMP imports in the UAE?
UAE health authorities, including MOHAP and EDE, regulate trials and imports, and ethics committees approve studies. Confirm which body applies to your specific trial.

Do clinical trial supplies need to follow GDP?
Yes. IMP storage and transport should follow Good Distribution Practice, alongside Good Clinical Practice for the trial itself.

Can investigational products be stored with commercial stock?
No. IMPs should be segregated from commercial stock with clear status control and restricted access.

How can sponsors reduce temperature excursion risk in the UAE?
Use validated packaging or temperature-controlled vehicles, monitor continuously, plan loading and handover carefully, and have an excursion response plan ready.

How do I choose a CRO logistics partner in the UAE?
Look for GDP-compliant facilities, experience with investigational and controlled products, real-time monitoring, strong documentation and reliable site coordination.

Support your trial with secure, compliant logistics

Clinical research in the UAE rewards early planning, accurate paperwork and dependable execution at every site. Arib Health (Arib Shipping) supports sponsors and CROs with secure, temperature-controlled and traceable transport of investigational products, from warehouse to hospital.

👉 Explore our pharmaceutical logistics services | Learn about clinical trial supply chain solutions | Talk to our team

Useful official sources: MOHAP · Dubai Health Authority · WHO: Clinical trials